These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30353064)

  • 61. [Hematopoietic reconstitution on the prognosis of hematological malignancies after allogeneic hematopoietic stem cell transplantation].
    Zhang Y; Ren HY; Qiu ZX; Wang MJ; Xu WL; Liu W; Li Y; Dong YJ; Yin Y; Sun YH; Wang LH; Ou JP; Wang WS; Cen XN
    Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):747-50. PubMed ID: 23336230
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mononuclear Cell Telomere Attrition Is Associated with Overall Survival after Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies.
    Helby J; Petersen SL; Kornblit B; Nordestgaard BG; Mortensen BK; Bojesen SE; Sengeløv H
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):496-504. PubMed ID: 30266676
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation.
    Simonetta F; Masouridi-Levrat S; Beauverd Y; Tsopra O; Tirefort Y; Koutsi A; Stephan C; Polchlopek-Blasiak K; Pradier A; Dantin C; Ansari M; Roosnek E; Chalandon Y
    Leuk Lymphoma; 2018 Mar; 59(3):590-600. PubMed ID: 28679328
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation.
    Au BK; Gooley TA; Armand P; Fang M; Madtes DK; Sorror ML; Boeckh MJ; Gibson CJ; Deeg HJ; Storb R; Appelbaum FR; Chien JW; Martin PJ
    Biol Blood Marrow Transplant; 2015 May; 21(5):848-54. PubMed ID: 25644959
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Positive psychological experiences in allogeneic hematopoietic stem cell transplantation.
    Amonoo HL; Brown LA; Scheu CF; Millstein RA; Pirl WF; Vitagliano HL; Antin JH; Huffman JC
    Psychooncology; 2019 Aug; 28(8):1633-1639. PubMed ID: 31128072
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical significance of pre- and 1-year post-transplant serum ferritin among adult transplant recipients.
    Tachibana T; Tanaka M; Numata A; Matsumoto K; Tomita N; Fujimaki K; Taguchi J; Sakai R; Fujita H; Fujisawa S; Maruta A; Ishigatsubo Y; Kanamori H
    Leuk Lymphoma; 2014 Jun; 55(6):1350-6. PubMed ID: 24024470
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients.
    Turki AT; Lamm W; Schmitt C; Bayraktar E; Alashkar F; Metzenmacher M; Wohlfarth P; Beelen DW; Liebregts T
    Ann Hematol; 2019 Feb; 98(2):491-500. PubMed ID: 30406350
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies.
    Luo Y; Zeng HQ; Shen Y; Zhang P; Lou SF; Chen L; Deng JC
    Leuk Res; 2016 Sep; 48():6-10. PubMed ID: 27416327
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predictive value of risk assessment scores in patients with hematologic malignancies undergoing reduced-intensity conditioning allogeneic stem cell transplantation.
    Yamamoto W; Ogusa E; Matsumoto K; Maruta A; Ishigatsubo Y; Kanamori H
    Am J Hematol; 2014 Sep; 89(9):E138-41. PubMed ID: 24845702
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Positive Psychological Constructs and Health Outcomes in Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
    Amonoo HL; Barclay ME; El-Jawahri A; Traeger LN; Lee SJ; Huffman JC
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):e5-e16. PubMed ID: 30308327
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-up.
    Patil S; Spencer A; Schwarer A; Lewis I; Hertzberg M; Avery S; Wei A; Noutsos T; Paul E; Taouk Y; Muirhead J
    Bone Marrow Transplant; 2010 Jul; 45(7):1154-60. PubMed ID: 19898502
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Refinement of the Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.
    Shibasaki Y; Suwabe T; Katagiri T; Tanaka T; Ushiki T; Fuse K; Sato N; Yano T; Kuroha T; Hashimoto S; Narita M; Furukawa T; Sone H; Masuko M
    Int J Hematol; 2018 Sep; 108(3):282-289. PubMed ID: 29744806
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk factors predicting graft-versus-host disease and relapse-free survival after allogeneic hematopoietic stem cell transplantation in relapsed or refractory non-Hodgkin's lymphoma.
    Jeon YW; Yoon S; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG
    Ann Hematol; 2019 Jul; 98(7):1743-1753. PubMed ID: 31089793
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Donor Lymphocyte Infusions Used to Treat Mixed-Chimeric and High-Risk Patient Populations in the Relapsed and Nonrelapsed Settings after Allogeneic Transplantation for Hematologic Malignancies Are Associated with High Five-Year Survival if Persistent Full Donor Chimerism Is Obtained or Maintained.
    Caldemeyer LE; Akard LP; Edwards JR; Tandra A; Wagenknecht DR; Dugan MJ
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1989-1997. PubMed ID: 28712934
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The cell composition of infused donor lymphocyte has different impact in different types of allogeneic hematopoietic stem cell transplantation.
    Zhao XS; Wang Y; Yan CH; Wang JZ; Zhang XH; Xu LP; Liu KY; Huang XJ
    Clin Transplant; 2014 Aug; 28(8):926-34. PubMed ID: 24931494
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation.
    Tanaka Y; Kurosawa S; Tajima K; Tanaka T; Ito R; Inoue Y; Okinaka K; Inamoto Y; Fuji S; Kim SW; Tanosaki R; Yamashita T; Fukuda T
    Bone Marrow Transplant; 2016 Apr; 51(4):553-9. PubMed ID: 26752142
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants.
    Majhail NS; Brunstein CG; McAvoy S; DeFor TE; Al-Hazzouri A; Setubal D; Arora M; Le CT; Wagner JE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2008 Sep; 14(9):985-992. PubMed ID: 18721761
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Psychiatric and psychosocial challenges in patients undergoing haematopoietic stem cell transplants.
    Rueda-Lara M; Lopez-Patton MR
    Int Rev Psychiatry; 2014 Feb; 26(1):74-86. PubMed ID: 24716502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.